{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:24:24Z","timestamp":1776939864774,"version":"3.51.4"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004920","name":"Royan Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.abb.2025.110306","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T07:19:57Z","timestamp":1736839197000},"page":"110306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["c-FLIP\/Ku70 complex; A potential molecular target for apoptosis induction in hepatocellular carcinoma"],"prefix":"10.1016","volume":"765","author":[{"given":"Yasamin","family":"Haghir-Sharif-Zamini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustapha","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Zarrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massoud","family":"Vosough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.abb.2025.110306_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1280308","article-title":"The double-edged sword role of hydrogen sulfide in hepatocellular carcinoma","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.abb.2025.110306_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245749","article-title":"New insights on liver-directed therapies in hepatocellular carcinoma","volume":"15","author":"Dalzell","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.abb.2025.110306_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123202","article-title":"Pathogenesis and current treatment strategies of hepatocellular carcinoma","volume":"10","author":"T\u00fcmen","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151284","article-title":"Immunotherapeutic approaches in Hepatocellular carcinoma: building blocks of hope in near future","volume":"102","author":"Minaei","year":"2023","journal-title":"Eur. J. Cell Biol."},{"issue":"5","key":"10.1016\/j.abb.2025.110306_bib7","first-page":"266","article-title":"Current and future systemic therapies for hepatocellular carcinoma","volume":"15","author":"Bteich","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.abb.2025.110306_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081582","article-title":"Hepatocellular carcinoma: current drug therapeutic status, advances and challenges","volume":"16","author":"Zheng","year":"2024","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.abb.2025.110306_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101345","article-title":"HCC and molecular targeting therapies: back to the future","volume":"9","author":"Rinaldi","year":"2021","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.abb.2025.110306_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/cdd.2012.8","article-title":"Identification of an acetylation-dependant Ku70\/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis","volume":"19","author":"Kerr","year":"2012","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib11","first-page":"176","article-title":"c-FLIP, a master anti-apoptotic regulator","volume":"34","author":"Safa","year":"2012","journal-title":"Exp. Oncol."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11030223","article-title":"Histone deacetylase inhibitors in the treatment of hepatocellular carcinoma: current evidence and future opportunities","volume":"11","author":"Garmpis","year":"2021","journal-title":"J. Personalized Med."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2741\/3691","article-title":"HDACi--going through the mechanisms","volume":"16","author":"Wanczyk","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.abb.2025.110306_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.960263","article-title":"Histone deacetylases modulate resistance to the therapy in lung cancer","volume":"13","author":"Contreras-Sanz\u00f3n","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.abb.2025.110306_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2025.110306_bib17","series-title":"Mechanisms Adopted by Cancer Cells to Escape Apoptosis- A Review, BIOCELL 45","author":"Dandoti","year":"2021"},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00436-023-08031-x","article-title":"Apoptosis and its pathways as targets for intracellular pathogens to persist in cells","volume":"123","author":"Rodr\u00edguez-Gonz\u00e1lez","year":"2023","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.abb.2025.110306_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","article-title":"Autophagy and apoptosis dysfunction in neurodegenerative disorders","volume":"112","author":"Ghavami","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.abb.2025.110306_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semcdb.2023.07.005","article-title":"Death and survival from executioner caspase activation","volume":"156","author":"Sun","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"issue":"17","key":"10.1016\/j.abb.2025.110306_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174363","article-title":"Apoptosis deregulation and the development of cancer multi-drug resistance","volume":"13","author":"Neophytou","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.abb.2025.110306_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1476-4431.2008.00363.x","article-title":"Apoptosis: a review of pro\u2010apoptotic and anti\u2010apoptotic pathways and dysregulation in disease","volume":"18","author":"O'Brien","year":"2008","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"10.1016\/j.abb.2025.110306_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.trecan.2021.12.002","article-title":"Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks","volume":"8","author":"Ivanisenko","year":"2022","journal-title":"Trends in Cancer"},{"issue":"17","key":"10.1016\/j.abb.2025.110306_bib25","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/jcmm.17873","article-title":"(-)-Epigallocatechin-3-gallate induced apoptosis by dissociation of c-FLIP\/Ku70 complex in gastric cancer cells","volume":"27","author":"Shahriari Felordi","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.abb.2025.110306_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4252\/wjsc.v13.i6.542","article-title":"Epigenetic regulation of autophagy: a key modification in cancer cells and cancer stem cells","volume":"13","author":"Mandhair","year":"2021","journal-title":"World J. Stem Cell."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41419-021-03553-7","article-title":"Autophagy, an accomplice or antagonist of drug resistance in HCC?","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.abb.2025.110306_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1159\/000485285","article-title":"Multiple roles of autophagy in the sorafenib resistance of hepatocellular carcinoma","volume":"44","author":"Sun","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.abb.2025.110306_bib29","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/leu.2014.19","article-title":"Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia","volume":"28","author":"El-Khoury","year":"2014","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.abb.2025.110306_bib30","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.3748\/wjg.v20.i17.4953","article-title":"Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells","volume":"20","author":"Yuan","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.abb.2025.110306_bib31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41419-024-06981-3","article-title":"HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.abb.2025.110306_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41419-024-06955-5","article-title":"Autophagy modulation attenuates sorafenib resistance in HCC induced in rats","volume":"15","author":"Elleithi","year":"2024","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.abb.2025.110306_bib33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","article-title":"Epidrugs: targeting epigenetic marks in cancer treatment","volume":"14","author":"Miranda Furtado","year":"2019","journal-title":"Epigenetics"},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biom12030367","article-title":"The role of epigenetic modifications in human cancers and the use of natural compounds as epidrugs: mechanistic pathways and pharmacodynamic actions","volume":"12","author":"Bouyahya","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.abb.2025.110306_bib35","series-title":"Abeloff's Clinical Oncology","first-page":"209","article-title":"14 - genetic and epigenetic alterations in cancer","author":"Teh","year":"2020"},{"key":"10.1016\/j.abb.2025.110306_bib36","article-title":"APC promoter methylation in gastrointestinal cancer","volume":"11","author":"Zhu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13046-022-02297-2","article-title":"Epigenetic remodelling in human hepatocellular carcinoma","volume":"41","author":"Braghini","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.abb.2025.110306_bib38","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/cas.14729","article-title":"P300-dependent acetylation of histone H3 is required for epidermal growth factor receptor-mediated high-mobility group protein A2 transcription in hepatocellular carcinoma","volume":"112","author":"Liang","year":"2021","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.abb.2025.110306_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034265","article-title":"HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer","volume":"7","author":"Xie","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.abb.2025.110306_bib40","doi-asserted-by":"crossref","first-page":"11523","DOI":"10.1007\/s13277-014-2358-2","article-title":"Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest","volume":"35","author":"Fan","year":"2014","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.abb.2025.110306_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060850","article-title":"Epigenetic regulation of TRAIL signaling: implication for cancer therapy","volume":"11","author":"Elmallah","year":"2019","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.abb.2025.110306_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16152728","article-title":"RNA-independent regulatory functions of lncRNA in complex disease","volume":"16","author":"Kafida","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.abb.2025.110306_bib43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","article-title":"Epigenetics in hepatocellular carcinoma","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrgastro.2017.169","article-title":"Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/livers2030017","article-title":"Non-coding RNAs in hepatocellular carcinoma","volume":"2","author":"Korsch","year":"2022","journal-title":"Liver"},{"key":"10.1016\/j.abb.2025.110306_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6049480","article-title":"Long noncoding RNAs act as novel biomarkers for hepatocellular carcinoma: progress and prospects","volume":"2017","author":"Bao","year":"2017","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.abb.2025.110306_bib47","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1097-2765(04)00094-2","article-title":"Acetylation of the C terminus of Ku70 by CBP and PCAF controls bax-mediated apoptosis","volume":"13","author":"Cohen","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.abb.2025.110306_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.761983","article-title":"The role of Ku70 as a cytosolic DNA sensor in innate immunity and beyond","volume":"11","author":"Sui","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.abb.2025.110306_bib49","article-title":"Acetylation of the nuclear localization signal in Ku70 diminishes the interaction with importin-\u03b1","volume":"33","author":"Fujimoto","year":"2023","journal-title":"Biochem Biophys Rep"},{"issue":"7","key":"10.1016\/j.abb.2025.110306_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071601","article-title":"Apoptosis induction byHistone deacetylase inhibitors in cancer cells: role of Ku70","volume":"20","author":"Gong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/jpm11030223","article-title":"Histone deacetylase inhibitors in the treatment of hepatocellular carcinoma: current evidence and future opportunities","volume":"11","author":"Garmpis","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.abb.2025.110306_bib52","article-title":"Roles of c-FLIP in apoptosis, necroptosis, and autophagy","volume":"6","author":"Safa","year":"2013","journal-title":"J Carcinog Mutagen Suppl"},{"issue":"2","key":"10.1016\/j.abb.2025.110306_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.biocel.2009.11.015","article-title":"Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer","volume":"42","author":"Bagnoli","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/cimb46010046","article-title":"The identification of new c-FLIP inhibitors for restoring apoptosis in TRAIL-resistant cancer cells","volume":"46","author":"Yaacoub","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"2","key":"10.1016\/j.abb.2025.110306_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2010.10.009","article-title":"Targeting c-FLIP in cancer","volume":"332","author":"Shirley","year":"2013","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib56","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1038\/s41467-024-47990-2","article-title":"Deciphering DED assembly mechanisms in FADD-procaspase-8-cFLIP complexes regulating apoptosis","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2025.110306_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1471216","article-title":"Targeting caspase-8\/c-FLIP(L) heterodimer in complex II promotes DL-mediated cell death","volume":"12","author":"Hillert-Richter","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"20","key":"10.1016\/j.abb.2025.110306_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205125","article-title":"TRAIL in the treatment of cancer: from soluble cytokine to nanosystems","volume":"14","author":"Alizadeh Zeinabad","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.abb.2025.110306_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.628332","article-title":"The TRAIL in the treatment of human cancer: an update on clinical trials","volume":"8","author":"Snajdauf","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.20517\/cdr.2022.82","article-title":"Nano-TRAIL: a promising path to cancer therapy","volume":"6","author":"Gampa","year":"2023","journal-title":"Cancer Drug Resist"},{"issue":"2","key":"10.1016\/j.abb.2025.110306_bib61","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41418-022-01059-z","article-title":"Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries","volume":"30","author":"Montinaro","year":"2023","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.abb.2025.110306_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1517\/14728222.2013.736499","article-title":"Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer","volume":"17","author":"Fulda","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.abb.2025.110306_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101312","article-title":"HDAC inhibitors: targets for tumor therapy, immune modulation and lung diseases","volume":"16","author":"Shanmugam","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.abb.2025.110306_bib64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/CMAR.S346052","article-title":"Targeted cancer therapy based on acetylation and deacetylation of key proteins involved in double-strand break repair","volume":"14","author":"Wang","year":"2022","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.abb.2025.110306_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21111608","article-title":"Natural compound histone deacetylase inhibitors (HDACi): synergy with inflammatory signaling pathway modulators and clinical applications in cancer","volume":"21","author":"Losson","year":"2016","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.abb.2025.110306_bib67","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2174\/1568026615666141208105614","article-title":"An overview of naturally occurring histone deacetylase inhibitors","volume":"14","author":"Kim","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.abb.2025.110306_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110907","article-title":"Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: mechanisms insights and efficiencies","volume":"392","author":"Aanniz","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.abb.2025.110306_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1116805","article-title":"Epigenetic reprogramming in cancer: from diagnosis to treatment","volume":"11","author":"Costa","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13148-019-0675-4","article-title":"Epigenetics in cancer therapy and nanomedicine","volume":"11","author":"Roberti","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.abb.2025.110306_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.605386","article-title":"Epidrug repurposing: discovering new faces of old acquaintances in cancer therapy","volume":"10","author":"Montalvo-Casimiro","year":"2020","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.abb.2025.110306_bib72","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.molonc.2015.06.002","article-title":"Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin","volume":"9","author":"Kuang","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.abb.2025.110306_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116902","article-title":"A new strategy for overcoming drug resistance in liver cancer: epigenetic regulation","volume":"176","author":"Su","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4_suppl","key":"10.1016\/j.abb.2025.110306_bib74","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1200\/JCO.2022.40.4_suppl.574","article-title":"A phase Ib study of guadecitabine and durvalumab in patients with advanced hepatocellular carcinoma, pancreatic adenocarcinoma, and biliary cancers","volume":"40","author":"Algaze","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib75","first-page":"vdad053","article-title":"Isocitrate dehydrogenase mutations in gliomas: a review of current understanding and trials","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol Adv"},{"issue":"4","key":"10.1016\/j.abb.2025.110306_bib76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41419-024-06625-6","article-title":"Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression","volume":"15","author":"Cui","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.abb.2025.110306_bib77","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22451","article-title":"Oncometabolite D-2-Hydroxyglutarate enhances gene silencing through inhibition of specific H3K36 histone demethylases","volume":"6","author":"Janke","year":"2017","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.abb.2025.110306_bib78","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.suronc.2018.07.015","article-title":"Histone deacetylase inhibitors in hepatocellular carcinoma: a therapeutic perspective","volume":"27","author":"Tsilimigras","year":"2018","journal-title":"Surg Oncol"},{"key":"10.1016\/j.abb.2025.110306_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114886","article-title":"Molecular mechanisms underlying the clinical efficacy of panobinostat involve Stochasticity of epigenetic signaling, sensitization to anticancer drugs, and induction of cellular cell death related to cellular stresses","volume":"164","author":"El Omari","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.abb.2025.110306_bib80","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/1756283X16644247","article-title":"Epigenetic therapy in gastrointestinal cancer: the right combination","volume":"9","author":"Abdelfatah","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"issue":"8","key":"10.1016\/j.abb.2025.110306_bib81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/COC.0000000000000567","article-title":"Phase I study of sorafenib and Vorinostat in advanced hepatocellular carcinoma","volume":"42","author":"Gordon","year":"2019","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.abb.2025.110306_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115212","article-title":"Anticancer clinical efficiency and stochastic mechanisms of belinostat","volume":"165","author":"El Omari","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.abb.2025.110306_bib83","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical toxicities of histone deacetylase inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.abb.2025.110306_bib84","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphar.2019.00385","article-title":"DNMT inhibitors increase methylation in the cancer genome","volume":"10","author":"Giri","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13148-022-01419-z","article-title":"Drugging the epigenome in the age of precision medicine","volume":"15","author":"Feehley","year":"2023","journal-title":"Clin. Epigenet."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib86","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib87","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8496","article-title":"Modulating epigenetic modifications for cancer therapy","volume":"49","author":"Castro-Mu\u00f1oz","year":"2023","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.abb.2025.110306_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010376","article-title":"c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589","volume":"5","author":"Kauh","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.abb.2025.110306_bib89","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biochi.2011.06.031","article-title":"SAHA\/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells","volume":"94","author":"Lauricella","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.abb.2025.110306_bib90","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-014-0088-y","article-title":"c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors","volume":"7","author":"Zheng","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12013-014-0428-0","article-title":"Epigallocatechin-3-gallate sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis","volume":"72","author":"Wei","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.abb.2025.110306_bib92","doi-asserted-by":"crossref","first-page":"16367","DOI":"10.18632\/oncotarget.14829","article-title":"The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib\/dabrafenib-resistant melanoma cells in vitro and in vivo","volume":"8","author":"Booth","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-9966-28-24","article-title":"Expression and biological significance of c-FLIP in human hepatocellular carcinomas","volume":"28","author":"Du","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib94","first-page":"227","article-title":"Histone deacetylase inhibition by valproic acid down-regulates c-FLIP\/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy","volume":"15","author":"Schuchmann","year":"2006","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.abb.2025.110306_bib95","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.lfs.2013.01.017","article-title":"Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals","volume":"92","author":"Abou El Naga","year":"2013","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib96","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.biocel.2012.12.005","article-title":"Ku70 acetylation and modulation of c-Myc\/ATF4\/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIP","volume":"45","author":"Kim","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib97","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tranon.2016.01.004","article-title":"Droxinostat, a histone deacetylase inhibitor, induces apoptosis in hepatocellular carcinoma cell lines via activation of the mitochondrial pathway and downregulation of FLIP","volume":"9","author":"Liu","year":"2016","journal-title":"Transl Oncol"},{"issue":"9","key":"10.1016\/j.abb.2025.110306_bib98","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1158\/1535-7163.MCT-20-1050","article-title":"Clinical positioning of the IAP antagonist tolinapant (ASTX660) in colorectal cancer","volume":"20","author":"Crawford","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"issue":"24","key":"10.1016\/j.abb.2025.110306_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415671","article-title":"The combination of panobinostat and melphalan for the treatment of patients with multiple myeloma","volume":"23","author":"Gkotzamanidou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib100","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2402588","article-title":"EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory protein","volume":"25","author":"Guo","year":"2024","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib101","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13046-021-01968-w","article-title":"Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets","volume":"40","author":"Luo","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib102","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.prp.2015.12.012","article-title":"The DNA damage repair protein Ku70 regulates tumor cell and hepatic carcinogenesis by interacting with FOXO4","volume":"212","author":"Zhang","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.abb.2025.110306_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0602-1","article-title":"HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue","volume":"9","author":"Gong","year":"2018","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.abb.2025.110306_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054885","article-title":"Translational control of metabolism and cell cycle progression in hepatocellular carcinoma","volume":"24","author":"Scagliola","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.abb.2025.110306_bib105","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","article-title":"c-Myc and cancer metabolism","volume":"18","author":"Miller","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"46","key":"10.1016\/j.abb.2025.110306_bib106","doi-asserted-by":"crossref","first-page":"34725","DOI":"10.1074\/jbc.R600017200","article-title":"The ins and outs of MYC regulation by posttranslational mechanisms","volume":"281","author":"Vervoorts","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.abb.2025.110306_bib107","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/hep.25891","article-title":"Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.abb.2025.110306_bib108","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3748\/wjg.v22.i1.275","article-title":"Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma","volume":"22","author":"Haruyama","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.abb.2025.110306_bib109","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154515","article-title":"\u03b2-Catenin signaling in hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.abb.2025.110306_bib110","article-title":"Glypican-3: a novel and promising target for the treatment of hepatocellular carcinoma","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.abb.2025.110306_bib111","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1158\/1078-0432.CCR-15-2388","article-title":"c-Myc modulation and acetylation is a key HDAC inhibitor target in cancer","volume":"23","author":"Nebbioso","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.abb.2025.110306_bib112","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1128\/MCB.24.19.8418-8427.2004","article-title":"Cellular FLIP inhibits beta-catenin ubiquitylation and enhances Wnt signaling","volume":"24","author":"Naito","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.abb.2025.110306_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071589","article-title":"Drug repurposing: the mechanisms and signaling pathways of anti-cancer effects of anesthetics","volume":"10","author":"Wu","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.abb.2025.110306_bib114","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050410","article-title":"Repurposing old drugs into new epigenetic inhibitors: promising candidates for cancer treatment?","volume":"12","author":"Moreira-Silva","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.abb.2025.110306_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.849895","article-title":"Impact of local anesthetics on epigenetics in cancer","volume":"12","author":"Bezu","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.abb.2025.110306_bib116","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12072-007-9014-5","article-title":"Procaine inhibits the proliferation and DNA methylation in human hepatoma cells","volume":"1","author":"Tada","year":"2007","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.abb.2025.110306_bib117","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3390\/molecules23071614","article-title":"Garcinol enhances TRAIL-induced apoptotic cell death through up-regulation of DR5 and down-regulation of c-FLIP expression","volume":"23","author":"Kim","year":"2018","journal-title":"Molecules"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T08:09:41Z","timestamp":1746000581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986125000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":116,"alternative-id":["S0003986125000190"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2025.110306","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c-FLIP\/Ku70 complex; A potential molecular target for apoptosis induction in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2025.110306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110306"}}